首页> 外文期刊>National Journal of Laboratory Medicine >Screening of Prostate Cancer by Prostate Specific Antigen and its Prevalence in Jammu Region
【24h】

Screening of Prostate Cancer by Prostate Specific Antigen and its Prevalence in Jammu Region

机译:占木地区前列腺特异性抗原的筛选及其患病率

获取原文
           

摘要

Introduction: Prostate cancer is most commonly diagnosed non-cutaneous cancer in men. Prostate specific antigen is the biomarker used for screening of prostate cancer and prostate related problems. Not only the genetic factors are involved, dietary factors and environmental factors are also responsible for the development of prostate cancer. Risk factors like family history, age, chemical exposure, infection and smoking are at the peak point for the development of prostatic disease. Advanced age is one of the main risk factor. Most commonly prostate abnormalities are seen among male patients of 50 years and above. Early screening using PSA reduces the incidence rate of prostate cancer.Aim: Aim of our study is to use PSA as biomarker to screen male population for prostate related problems, to compare its levels in smokers and non smokers and to detect the prevalence of prostate cancer in Jammu region.Materials and Methods: The study was conducted in department of Biochemistry, Super speciality hospital, Government Medical College Jammu. 3 ml blood sample was collected from antecubital vein under aseptic precautions in a plain vacutainer and incubated at room temperature; serum was separated by centrifuge machine at 2000 rpm for 5 minutes. The samples were analyzed by Abott Architect Auto analyser using Chemiluminescent Microparticle Immunoaasay (CMIA). A total 150 males of age 50 years and above who had prostate related problems were screened using PSA as biomarker.Results: Our study showed that the mean PSA levels in normal persons were 2.59 ng/dl whereas in patients with BPH the mean levels were comparatively high i.e. 6.89 ng/dl and were very high in patients with prostate cancer i.e. 21.18 ng/dl. Similarly, the mean levels of PSA in smokers were comparatively high (12.13 ng/dl) as compared to non-smokers (10.18ng/dl) Prevalence of prostate cancer cases in Jammu district was estimated to be 15% per year.Conclusion: Screening of men for prostatic problems by using PSA is helpful in early detection of prostate cancer. There is a significant association between smoking and PSA levels.
机译:简介:前列腺癌是男性最常被诊断的非皮肤癌。前列腺特异性抗原是用于筛选前列腺癌和前列腺相关问题的生物标志物。不仅涉及遗传因素,饮食因素和环境因素也导致前列腺癌的发展。家族病史,年龄,化学暴露,感染和吸烟等风险因素正处于前列腺疾病发展的高峰期。高龄是主要危险因素之一。在50岁以上的男性患者中最常见的是前列腺异常。使用PSA进行早期筛查可降低前列腺癌的发生率。目的:我们的研究目的是使用PSA作为生物标记物来筛查男性人群中与前列腺相关的问题,比较其在吸烟者和非吸烟者中的水平以及检测前列腺癌的患病率材料与方法:本研究在查mu政府医学院超级专科医院生物化学系进行。在无菌预防措施下,在平顶真空容器中从肘前静脉采集3 ml血样,并在室温下孵育;通过离心机以2000rpm分离血清5分钟。样品由Abott Architect Auto分析仪使用化学发光微粒免疫分析(CMIA)进行分析。结果:我们的研究表明,正常人的平均PSA水平为2.59 ng / dl,而BPH患者的平均PSA水平相对较高,对150名年龄在50岁及以上的前列腺相关问题男性进行了筛查。高,即6.89 ng / dl,在前列腺癌患者中非常高,即21.18 ng / dl。同样,与不吸烟者(10.18ng / dl)相比,吸烟者的PSA平均水平相对较高(12.13 ng / dl)。据估计,占木地区的前列腺癌病例每年为15%。男性使用PSA治疗前列腺问题有助于早期发现前列腺癌。吸烟与PSA水平之间存在显着关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号